Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 171 results for "Cgix"

Cancer Genetics' (CGIX) CEO Panna Sharma on Q2 2016 Results - ...

Cancer Genetics Incorporated (NASDAQ: CGIX ) Q2 2016 Earnings Conference Call August 10, 2016 08:30 AM ET Executive Edward Sitar - CFO Panna Sharma - President and CEO Jay Roberts - COO Analyst Ben Haynor - Feltl and Company ... Seeking Alpha, 2 weeks ago
Margins Are Key For NeoGenomics In Q2 2016 Seeking Alpha, 1 month ago

17 images for Cgix

Nasdaq, 2 weeks ago
SleekMoney, 4 weeks ago
SleekMoney, 3 months ago
American Banking News - Forex, 3 months ago
American Banking News - Forex, 4 months ago
American Banking News, 4 months ago
SleekMoney, 4 months ago
American Banking News, 4 months ago
American Banking News - Forex, 5 months ago
SleekMoney, 5 months ago

Cancer Genetics beats by $0.05, beats on revenue

ews Editor Cancer Genetics (NASDAQ:CGIX): Q2 EPS of -$0.28 beats by $0.05. Revenue of $7M (+67.5% Y/Y) beats
 Seeking Alpha2 weeks ago

Cancer Genetics: 'Warrant,' You Are Under Arrest

Introduction I penned two articles over the past couple of months, claiming that Cancer Genetics, Inc. (NASDAQ: CGIX ) was running out of money and going to need capital soon. As it turns out, I was correct. On May 25, 2016, CGI issued a direct ...
 Seeking Alpha1 month ago

Cancer Genetics, Inc. Reports Second Quarter 2016 Financial Results and Provides Company Updates

GlobeNewswire 2016-08-09 RUTHERFORD, N.J., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in molecular and biomarker-based cancer diagnostics, announced today financial and operating results for the ...
 BizWire Express2 weeks ago Cancer Genetics to Report Second Quarter Earnings on Wednesday, August 10  Yahoo! Finance3 weeks ago Cancer Genetics Inc. Selected by H3 Biomedicine Inc., to Provide Biomarker Discovery and Testing for a Global Drug Development Program in Hematologic Cancers  BizWire Express1 month ago Cancer Genetics Names John Jay Roberts as COO and EVP of Finance  Citybizlist2 months ago
[x]  
Nasdaq

Healthcare Stocks' Q2 Earnings on Aug 10: QHC, CDNA & CGIX

Medical is one of the 10 sectors in the S&P 500 cohort that is expected to witness earnings growth in the second quarter. The sector's earnings are likely to increase 4.4% on a revenue hike of 7.7%. We note that 433 S&P companies have already ...
 Yahoo! Singapore2 weeks ago
[x]  

Cancer Genetics Inc. (CGIX) Set to Announce Earnings on Wednesday

Cancer Genetics Inc. (NASDAQ:CGIX) is scheduled to be issuing its Q216 quarterly earnings data on Wednesday, August 10th. Analysts expect the company to announce earnings of ($0.33) per share and revenue of $6.50 million for the quarter. Cancer ...
 SleekMoney2 weeks ago Cancer Genetics Inc. (CGIX) Posts Earnings Results, Beats Expectations By $0.05 EPS  SleekMoney2 weeks ago Cancer Genetics Inc. (CGIX) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS  Ticker Report2 weeks ago Cancer Genetics Inc. (CGIX) Announces Earnings Results  Zolmax News2 weeks ago
[x]  

Zacks: Cancer Genetics Inc. (NASDAQ:CGIX) Receives Average Rating of Strong Buy from Analysts

Cancer Genetics Inc. (NASDAQ:CGIX) has received an average broker rating score of 1.00 (Strong Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.
 WKRB News3 weeks ago
SleekMoney

Stock Analysts Downgrades for July, 29th (ACFC, ACHI, ACW, ALDR, ANSS, ATHX, AUDC, AVAV, BHLB, CGIX)

Stock Analysts downgrades for Friday, July 29th: Atlantic Coast Financial Corp. (NASDAQ:ACFC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, Atlantic Coast Financial Corporation, ...
 SleekMoney4 weeks ago

Health Care Sector Update for 06/30/2016: CGIX

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is
 Nasdaq1 month ago

CANCER GENETICS (CGIX)

. CANCER GENETICS (NASDAQ:CGIX) Smart Scan Chart Analysis confirms that a short term counter trend move is underway. When this action is over look for the longer term negative trend to resume. Downtrend with money management stops. The ...
 INO.com2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less